Auberton-Herve Andre-Jacques's Form 4 filing
Bionik Laboratories Corp. (BNKL) · filed Jun 21, 2023
- Accession no.
- 0001104659-23-073231
- Filed
- Jun 21, 2023
- Trade date
- Jun 13, 2023
- Filing delay
- 8 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed 8 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Auberton-Herve Andre-JacquesCIK 0001730329 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock | CConversionAcquired | +186,111 | $0.60F1 | +$111,666.6 | 1,109,271 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +366,667 | $220,000.00 | +$220,000 | 1 | Indirect | Price outlier |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Effective as of June 13, 2023, approximately $310,185 of principal and accrued interest of a convertible promissory note issued to Star SCI, an affiliate of the reporting person, converted in accordance with its terms into 186,111 shares of the Issuer's common stock
Referenced by the price of 1 transaction in Table I.